Clinical Trial Details

EORTC-1408-BCG

Back to Clinical Trials Database

Aiming to Understand the MOlecular Aberrations in Metastatic Breast Cancer

Study documentation

Trial Status Recruiting
Dates Date of activation: 01-Apr-2014
Date Step1 close: 01-Mar-2021
Data management at EORTC No
Design Cohort
Not randomized / N.A.
Targeted Sample size EORTC Groups: 300 - All Groups: 1300
Treatment
Study Staff Fatima Cardoso (Study Coordinator) , Champalimaud Clinical Center, Lisboa
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Jessica Berger (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels
Christine Bourguignon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Luminita Copaceanu (Lead CRA) , EORTC Headquarters, Brussels
Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Jelle Stans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Egle Venslovaite (Project Manager) , EORTC Headquarters, Brussels
Type of cancer Breast
Participating groups EORTC Breast Cancer Group
Breast International Group
ETOP IBCSG Partners Foundation
Recruiting centers C.H.U. Sart-Tilman (Liege, Belgium)
CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
Centre Hospitalier De Luxembourg (Luxembourg, Luxembourg)
Champalimaud Clinical Center (Lisboa, Portugal)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
Grand Hopital de Charleroi - Site Notre Dame (Charleroi, Belgium)
Institut Jules Bordet (Anderlecht, Belgium)
NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom)
NHS Lothian - Western General Hospital (Edinburgh, United Kingdom)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Protocol summary http://clinicaltrials.gov/study/NCT02102165
NCT number NCT02102165
Financial Support External Grant